The filing is a routine investor presentation disclosure with no extractable content. Monitor for future filings or press releases that may contain pipeline updates or financial results.
Price Chart
Executive Summary
Dare Bioscience filed an 8-K on September 9, 2026, to furnish a corporate investor presentation (Exhibit 99.1) under Item 7.01 Regulation FD. The presentation is intended for use in meetings with market participants. No financial results, guidance, or material corporate events were disclosed in the filing text itself; the exhibit content was provided only as unreadable binary graphic files, preventing extraction of any specific pipeline updates, financial data, or strategic commentary.
Key Facts
- Filing is a routine Regulation FD disclosure of a corporate investor presentation.
- Presentation dated September 9, 2026, furnished as Exhibit 99.1 but content unavailable for analysis.
- No financial results, guidance, or material definitive agreements disclosed in the 8-K text.
Financial Impact
No financial data available in the filing text; presentation content could not be read.
Risk Factors
- Presentation content is unknown; may contain forward-looking statements or pipeline updates that could move the stock.
- Low market cap ($14M) micro-cap biotech is inherently volatile; any news flow can cause disproportionate price swings.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-041904 |
| Document: 0001493152-26-041904-index-headers.html | 0001493152-26-041904 |
| Document: 0001493152-26-041904-index.html | 0001493152-26-041904 |
| Document: 0001493152-26-041904.txt | 0001493152-26-041904 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 19d ago | DEF 14A | $0.7900 $0.7720 | ▲ +2.28% | ▲ +1.86% | $0.6467 (+18.14%) |
Oct 1, 2026 25d ago | 8-K | $0.8510 $0.8428 | ▼ −0.96% | ▼ −1.70% | $0.6467 (−24.01%) |
Sep 9, 2026 6w ago | 8-K | $0.7166 $0.7051 | ▼ −1.60% | ▼ −1.01% | $0.6467 (−9.75%) |
Sep 4, 2026 7w ago | EFFECT | $0.7210 $0.7130 | ▲ +1.11% | ▲ +0.56% | $0.6467 (+10.31%) |
Aug 17, 2026 10w ago | 8-K | $0.8102 $0.7682 | ▲ +5.18% | ▲ +4.51% | $0.6467 (+20.18%) |
Aug 17, 2026 10w ago | 424B5 | $0.8102 $0.7682 | ▲ +5.18% | ▲ +4.51% | $0.6467 (+20.18%) |
Aug 13, 2026 10w ago | 8-K | $0.9300 $0.8102 | ▼ −12.88% | ▼ −12.41% | $0.6467 (−30.46%) |
Aug 6, 2026 11w ago | Press Release | $1.33 $1.40 | ▲ +5.26% | ▲ +4.65% | $0.6467 (−51.38%) |
Jul 24, 2026 13w ago | 8-K | $1.28 $1.32 | ▲ +3.13% | ▲ +3.10% | $0.6467 (−49.48%) |
Jul 13, 2026 15w ago | 8-K | $2.09 $2.07 | ▼ −0.96% | ▼ −1.31% | $0.6467 (−69.06%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers